1 - 3 out of 3Page size: 10
  1. 2025

  2. Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone

    Patrushev, S. S., Kichkina, D. O., Moralev, A. D., Rybalova, T. V., Krasnov, V. I., Chernyak, E. I., Zenkova, M. A., Markov, A. V. & Shults, E. E., Feb 2025, In: Bioorganic Chemistry. 155, 108124.

    Research output: Contribution to journal › Article › peer-review

  3. 2023

  4. A Novel 3-meta-Pyridine-1,2,4-oxadiazole Derivative of Glycyrrhetinic Acid as a Safe and Promising Candidate for Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells

    Moralev, A. D., Salomatina, O. V., Chernikov, I. V., Salakhutdinov, N. F., Zenkova, M. A. & Markov, A. V., 26 Dec 2023, In: ACS Omega. 8, 51, p. 48813-48824 12 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2022

  6. Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo

    Salomatina, O. V., Sen’kova, A. V., Moralev, A. D., Savin, I. A., Komarova, N. I., Salakhutdinov, N. F., Zenkova, M. A. & Markov, A. V., 1 Jun 2022, In: International Journal of Molecular Sciences. 23, 11, 6214.

    Research output: Contribution to journal › Article › peer-review

ID: 16164541